Rhumbline Advisers Sells 15,149 Shares of Azenta, Inc. (NASDAQ:AZTA)

Rhumbline Advisers trimmed its stake in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 13.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 96,504 shares of the company's stock after selling 15,149 shares during the quarter. Rhumbline Advisers owned approximately 0.21% of Azenta worth $3,343,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Dimensional Fund Advisors LP grew its position in Azenta by 0.9% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,033,171 shares of the company's stock worth $151,659,000 after acquiring an additional 26,929 shares during the last quarter. Schroder Investment Management Group grew its position in Azenta by 46.7% during the 4th quarter. Schroder Investment Management Group now owns 1,405,056 shares of the company's stock worth $70,183,000 after acquiring an additional 447,292 shares during the last quarter. Lord Abbett & CO. LLC bought a new stake in shares of Azenta in the 4th quarter worth approximately $47,350,000. Federated Hermes Inc. grew its position in shares of Azenta by 65.9% in the 4th quarter. Federated Hermes Inc. now owns 762,189 shares of the company's stock worth $38,109,000 after buying an additional 302,786 shares during the last quarter. Finally, Royce & Associates LP grew its position in shares of Azenta by 2.4% in the 4th quarter. Royce & Associates LP now owns 758,068 shares of the company's stock worth $37,903,000 after buying an additional 18,091 shares during the last quarter. 99.08% of the stock is currently owned by institutional investors.

Azenta Trading Up 0.6%

Shares of AZTA stock traded up $0.19 during trading hours on Friday, reaching $30.60. The company's stock had a trading volume of 681,355 shares, compared to its average volume of 701,420. The stock has a market capitalization of $1.40 billion, a P/E ratio of -10.27 and a beta of 1.62. Azenta, Inc. has a one year low of $23.91 and a one year high of $63.58. The firm's fifty day simple moving average is $27.32 and its 200 day simple moving average is $39.32.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. During the same period in the prior year, the business earned $0.06 EPS. The firm's revenue was up 5.1% compared to the same quarter last year. As a group, equities research analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on AZTA shares. TD Cowen upgraded Azenta to a "hold" rating in a research report on Thursday, February 27th. Needham & Company LLC cut their price objective on Azenta from $59.00 to $40.00 and set a "buy" rating on the stock in a research report on Wednesday, May 7th.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.